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Abstract The trace mineral selenium (Se) is an essential ele-
ment for human and animal nutrition. The addition of Se to the
diet through dietary supplements or fortified food/feed is in-
creasingly common owing to the often sub-optimal content of
standard diets of many countries. Se supplements commercial-
ly available include the inorganic mineral salts such as sodium
selenite or selenate, and organic forms such as Se-enriched
yeast. Today, Se yeast is produced by several manufacturers
and has become the most widely used source of Se for human
supplementation and is also widely employed in animal nutri-
tion where approval in all species has been granted by regu-
latory bodies such as the European Food Safety Authority
(EFSA). Characterisation and comparison of Se-enriched
yeast products has traditionally been made by quantifying
total selenomethionine (SeMet) content. A disadvantage of
this approach, however, is that it does not consider the effects
of Se deposition on subsequent digestive availability. In this
study, an assessment wasmade of the water-soluble extracts of
commercially available Se-enriched yeast samples for free,
peptide-bound and total water-soluble SeMet. Using LC-
MS/MS, a total of 62 Se-containing proteins were identified
across four Se yeast products, displaying quantitative/
qualitative changes in abundance relative to the certified ref-
erence material, SELM-1 (P value <0.05; fold change ≥2).
Overall, the study indicates that significant differences exist
between Se yeast products in terms of SeMet content, Se-
containing protein abundance and associated metabolic
pathways.
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Introduction
Selenium (Se) is an essential micronutrient for humans and
animals playing important roles in antioxidant function, thy-
roid hormone metabolism, reproduction and immune re-
sponses [1]. Supplementation of farm animal diets with Se is
stimulated by the beneficial effect of this element on animal
health and, consequently, by the improved quality of food-
stuffs of animal origin [2]. Furthermore, several studies on
animal models, cell lines and human intervention trials have
demonstrated cancer protective effects of selenium [3].
The compounds available for use as Se supplements in-
clude the inorganic forms, sodium selenite and sodium sele-
nate, and the organic forms, L-selenomethionine (SeMet) and
Se-enriched yeast [4]. Although the metabolism of both or-
ganic and inorganic Se forms shows certain similarities, not all
of these forms are metabolised alike, and humans have been
found to absorb and retain Se better from SeMet than from the
inorganic Se salts [5–7]. In a number of studies in humans and
animals, in particular, those on Se-deficient diets, the bioavail-
ability of Se from Se-enriched yeasts and the bioavailability of
SeMet has been shown to be approximately 1.5- to 2-fold
higher than that of inorganic forms of Se [8, 9]. Consequently,
the biological actions of Se depend not only on the amount but
also on the form of the Se source [10] and on the digestibility
and accessibility of selenoamino acids from the protein-rich
yeast matrix [11].
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Proteins containing Se in the form of SeMet residues are
not formally classified as selenoproteins but rather called
selenium-containing proteins [12]. Therefore, in the case of
organic Se products such as Se yeast, biological efficacy is
more dependent on the digestibility and accessibility of Se-
containing proteins and peptides present in commercial prep-
arations. An assessment of the composition of Se yeast prod-
ucts in the marketplace indicated that significant differences
exist between the products [13]; however, speciation studies
traditionally focused on the determination of low molecular
mass selenocompounds [12].
In recent years, the methodology used in classical proteo-
mics has been gradually incorporated into analytical specia-
tion studies. The application of both elemental and organic
mass spectrometry methods, usually preceded by liquid chro-
matography, has become commonplace in studies on
selenoproteins and selenium-containing proteins [14]. Proteo-
mic techniques such as liquid chromatography-tandem mass
spectrometry (LC-MS/MS) enable the study of the vast nature
of proteins and the correlation with their underlying biological
processes. This allows the identification of their abundance
changes, levels of production, post-translation modification,
amino acid substitutions and polymorphisms to be deter-
mined. For this reason, physiological and nutritional alter-
ations can play a pivotal role in altering the proteome of an
organism facilitating the differentiation and discrimination of
Se yeast products [15].
In this study, an assessment was made of the water-soluble
extracts of Se-enriched yeast samples for free, peptide-bound
and total water-soluble SeMet. LC-MS/MS was used to iden-
tify and quantify individual proteins present in the soluble
extracts. Protein identities were validated using UniProt, and
Gene Ontology classification was performed to define the
potential biological role of the identified proteins and their
relevance to animal health [16]. Characterisation of Se yeast
in this way provides a unique fingerprint of origin and ac-
counts for fate of Se during the production process, which is
paramount importance for regulatory and safety agencies [17].
The Se-enriched yeast certified reference material (SELM-1)
was used for the calibration of instruments and evaluation of
methods for the determination of SeMet, Met and total Se in
yeast. This appears to be the first reported study using gel-free
and label-free quantification for the proteomic assessment of
water-soluble extracts of Se-enriched yeast products.
Materials and Methods
Selenised Yeast Samples
Samples from three non-consecutive production batches of
four commercially available Se yeast products were used in
all biochemical and proteomic analyses. The certified
reference material, SELM-1, was the test material for the in-
ductively coupled plasma mass spectrometry (ICP-MS) vali-
dation study and control for proteomic analyses [18].
Extraction of Free, Bound and Total Selenomethionine
from Yeast Samples
Protease XIV and Trizma Base were obtained from Sigma.
Methanol (HPLC grade) and trifluoroacetic acid (TFA) were
supplied by Sigma. All chemicals used in this work were of
analytical-reagent grade or higher unless otherwise specified.
Sample Extraction of Total SeMet
Approximately 0.04 g of Se yeast sample was accurately
weighed into 1.5 mL microcentrifuge tubes. Protease enzyme
solution (13.33 mg Protease XIV in 0.5 mL of Tris buffer pH
7.5) was added and vortex mixed for 2 min. Samples were
ultrasonicated for 25 s at 80 % amplitude and the probe
washed with 250 μL enzyme solution into the 1.5 mL tube.
Some ice and water were placed into the microwave carousel,
and the microcentrifuge tubes were placed into the carousel
holder (up to 14 tubes per run). The extraction program was
operated for 15 min at a power output of 30 W. Extracted
samples were centrifuged at 14,000 rpm for 3 min. Superna-
tants were then transferred in to 15 mL centrifuge tubes. Pel-
lets were washed with water (0.9 mL) and vortex-mixed until
completely in solution. Samples were centrifuged at 14,
000 rpm for 6 min and supernatants added to the 15 mL
centrifuge tubes. This step was repeated three times. Volumes
were adjusted to 15 mL using water and mixed well before
removing an aliquot (2 mL) for filtration (0.25 μm) and dilu-
tion before analysis.
Sample Extraction of Water-Soluble Free SeMet
Approximately 0.5 g of Se yeast sample was accurately
weighed into 50 mL sterilin tubes. HPLC-grade water (5
mL) was added. Samples were placed on a shaker for
15 min at 300 rpm. Samples were then centrifuged at
8500 rpm for 10 min. Aliquots (2 mL) of supernatants were
filtered (0.25 μm) and diluted before analysis.
Sample Extraction of Water-Soluble-Bound SeMet
Water extracts (500 μL) were added to 13.33 mg of protease.
Samples were ultrasonicated for 25 s at 80 % amplitude and
the probe washed with 250 μL enzyme solution (6.667 mg
Protease XIV/250 μL) into 1.5 mL tubes. Some ice and water
were placed into the microwave carousel, and the
microcentrifuge tubes were placed into the carousel holder
(up to 14 tubes per run). The extraction program was operated
for 15 min at a power output of 30 W. The extracted samples
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were centrifuged at 14,000 rpm for 3 min. Supernatants were
then transferred into 15 mL centrifuge tubes. Volumes were
adjusted to 15 mL using water and mixed well before remov-
ing an aliquot (2 mL) for filtration (0.25 μm) and dilution
before analysis.
Instrumentation and Calibration
Separations were performed on an Agilent Zorbax RX-C8 4.6
× 250 mm 5 μm column using an Agilent Technologies 1260
infinity series LC system connected to an Agilent Technolo-
gies 7700× series ICP-MS. Themobile phase was water/meth-
anol/TFA (97.9:2.0:0.1) at a flow rate of 1 mL/min, and the
column temperature was set at 30 °C.
A Heinemann 130W ultrasonic-homogeniser (HTU SONI
130, USA) equipped with a 3 mm double step titanium probe
was used for sample preparation. A CEM Discover micro-
wave equipped with an Explorer SP-D Plus 24/48
autosampler was used for sample extraction. An ELGA
Purelab Flex S7 HPLC water system was used to produce
>18MΩ cm water, and samples were filtered using Chromafil
Xtra RC-20/25. The HPLC mobile phase was filtered with
Whatman Glass Microfibre Filters.
SeMet standard powder was obtained from Sigma (>98 %
by TLC). This was used to prepare a 100 mg/L stock solution
in 0.1 M HCl. Aliquots (0.1 mL) of this solution were frozen
and used fresh each day.
The instrument was calibrated over the range of 50 to
250 ppb SeMet (20.15 to 100.75 ppb Se as SeMet) as de-
scribed previously [19].
Sample Analysis for ICP-MS
Aliquots (2 mL) of the sample extracts were filtered into 2 mL
microcentrifuge tubes. Further dilutions were made using
HPLC-grade water and transferred to 2 mL HPLC vials for
analysis. Each sample was analysed in triplicate using an in-
jection volume of 45μL and monitored for isotopes 76Se, 77Se
and 78Se.
Sample Preparation for LC-MS
Protein concentration of water extracts (1/10 dilution) was
quantified using the Bradford assay, and all solutions were
adjusted to the same concentration. Approximately 150 μg
of protein was precipitated from each sample using TCA/
acetone precipitation. Samples were solubilised in 6 M
urea/2 M thiourea solution, and all samples were again adjust-
ed to the same concentration as necessary. Samples were re-
duced and alkylated, with DTTand IAA, respectively, follow-
ed by overnight trypsin digestion in the presence of
ProteaseMax (Promega) mass spectrometry-compatible deter-
gent [20]. Digestion activity was quenched by acidification,
and samples were desalted using C18 ZipTips (Millipore) prior
to analysis. Desalted samples were dried to completion and
resuspended in loading solvent (2 % (v/v) acetonitrile, 0.05 %
(v/v) TFA) immediately prior to LC-MS/MS analysis.
LC-MS/MS Analysis
The analysis of the water extracts was performed using a re-
verse phase column (15 cm × 75 μm inner diameter) packed
with 3 μm C18 particles (EASY-Spray; Thermo Scientific).
All samples were separated on a 2 h acetonitrile gradient (5–
35%) in 0.1 % formic acid at a flow rate of 300mL/min, using
the UltiMate 3000Nano LC system fromDionex. The LCwas
coupled to a Q-Exactive mass spectrometer (Thermo Fisher
Scientific) with up to the top 15 most abundant isotope pat-
terns selected for fragmentation (MS/MS) (Top 15 method).
The Q-Exactive was operated in data-dependent mode with
survey scans (MS) acquired at a resolution of 70,000 at m/z
400, while MS/MS scans were acquired at a resolution of 17,
500.
Data Analysis
The MS data were analysed using MaxQuant version 1.3.0.5
[21] with protein identification achieved through comparison
against the Saccharomyces cerevisiae reference strain S288C
database (www.yeastgenome.org). Carbamidomethylation of
cysteines was set as a fixed modification, while oxidation of
methionines, acetylation of N-terminals and selenium-sulphur
substitution were set as variable modifications. The maximum
peptide/protein false discovery rates (FDR) were set to 1 %
based on comparison to a reverse database. The label-free
quantitative (LFQ) algorithm was used to generate normalised
spectral intensities and infer relative protein abundance. Pro-
teins that matched to a contaminants database or the reverse
database were removed, and proteins were only retained in
final analysis if detected in at least two samples from at least
one product. Quantitative analysis was performed using a t
test to compare pairs of samples, and proteins with significant
change in abundance (P value <0.05; fold change ≥2) were
included in the quantitative results. Qualitative analysis was
also performed, to detect proteins that were found in at least
two batches of a particular product, but undetectable in the
comparison product.
Results and Discussion
Determination of Total, Free and Bound Selenomethionine
There is a common misconception that the level of SeMet is
an appropriate indication for the bioavailability of selenised
yeast preparations [22]. In actuality, selenium bioavailability
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depends on the digestion of Se-containing yeast, the absorp-
tion of Se from the intestinal tract and finally the transport and
biotransformation of Se into biologically active forms [11].
Therefore, estimation of adequate levels of Se in the diet re-
quires information not only of the total amount of Se but also
of the bio-accessible species in the sample [6, 23, 24]. Se-
enriched yeast has been extensively studied and fractionated
[12, 25] with SeMet reported as the major selenoamino acid in
water-soluble yeast extracts, replacing Met by simple compe-
tition. Se yeast products consist of dried and inactivated prep-
arations of S. cerevisiae; the final product is a light to dark
brown, free-flowing powder readily dispersible in water and
organic solvents [26–28]. Aqueous extraction allows the re-
covery of 15–25 % of Se [12] present predominately as
protein-bound SeMet [29, 30]; therefore, an enzymatically
assisted extraction method is typically used to determine total
SeMet content [11]. Essentially, larger SeMet-containing pro-
teins and peptides are broken down into free amino acids and
short-chain peptides liberating the selenoamino acid for detec-
tion [19]. Figure 1 shows the difference between the five yeast
products used in this study in terms of free, peptide-bound and
total water-soluble selenomethionine (P < 0.01).
There was significant variation noted in the product specif-
ic inter-batch levels of free, peptide-bound and total water-
soluble SeMet (P < 0.01) except for yeast product 2, which
did not display such inconsistency (P = 0.1 and 0.012, respec-
tively). Product 1 had the highest variability in peptide-bound
water-soluble SeMet across the three batches assessed. This
may be due to the age of the sample or alterations that may
have been made to the fermentation process between batches
[31]. Another factor which may contribute to variation in final
concentration of SeMet between batches and/or products is
the number of washes applied post-production. Typically,
the residual sodium selenite used during production is
removed by washing the yeast cream prior to drying [32]. It
has been proposed that some SeMet in yeast may not be in-
corporated chemically into Se-containing proteins but physi-
cally associated with cell wall constituents [3, 23]. As com-
mercial Se yeast preparations consist of dried and inactivated
fragments of S. cerevisiae, it is reasonable to assume that some
leaching may occur post-production and prior to drying [12].
Product 4 consistently contained the most free SeMet in
each batch, whereas product 3 contained the least. It is impor-
tant to make this distinction between total SeMet and free
SeMet, as only the free form of this selenoamino acid is avail-
able for non-specific incorporation into proteins in place of
methionine, leading to Se-containing proteins, representing a
biological pool of Se [7]. Unless selenium-containing proteins
and peptides are digested to liberate SeMet as a free amino
acid, then regardless of total Se and/or total SeMet content, the
Se source must undergo a metabolic transformation to sele-
nide prior to its assimilation [24, 33]. Hinojosa-Reyes et al.
[11, 34] reported that 89 % of total Se was extracted after
in vitro gastrointestinal (GI) digestion of a selenised yeast
standard, but surprisingly, only 41 % was quantified in the
form of free SeMet. Therefore, although this free selenoamino
acid appears to be the most abundant Se species in GI digests,
half of the total SeMet content in the extracts still seems to be
associated with Se-containing peptides after in vitro GI diges-
tion [35]. A similar study by Encinar et al. [12] examined the
composition of three commercial preparations of Se-enriched
yeast in terms of Se deposition within individual yeast frac-
tions. Each product was extracted with water followed by a
variety of enzymic digestions intended to liberate
selenocompounds associated with various polysaccharide
and protein portions. Their study on the recovery of the dif-
ferent classes of Se species demonstrated significant differ-
ences between Se yeast samples from different sources.
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Similarly, based on the values reported in the present study, it
is apparent that the profiles of water-extractable SeMet differ
markedly, indicating that all sources of ‘selenium yeast’ are
not alike. It is clear that the compartmentalisation of Se within
yeast matrix is different between preparations and is strain-
dependent [36] and, consequently, it is reasonable to expect
that these preparations will also differ in parameters such as
shelf-life, bioavailability and, indeed, toxicology [37]. How
these data related to actual bioavailability of selenium within
the animal can only be speculative [13]; therefore, simulated
in vitro GI digestion studies will be required to establish a
complete overview of bioavailable intake [11, 38].
Although enzymatic hydrolysis is a powerful tool for
distinguishing between fractions, it is clear that there are in-
herent difficulties with enzymatic release of SeMet which may
lead to lower recoveries [39]. For instance, SeMet may not be
fully liberated from the protein, peptide or other cellular com-
ponents with which it is associated, and it may be solubilised
in forms which get lost during the derivatisation or chroma-
tography steps or may interact non-specifically with sample
components [40]. It must also be noted that Se-containing
proteins are labile and prone to degradation after being ex-
tracted [41] leading to an underestimation of the Se content.
However, inclusion of the certified reference material, SELM-
1, in intercomparison Se speciation and quantitation studies,
validates the reported values [18].
A top-down proteomic approach incorporating liquid chro-
matography with tandemmass spectrometry can also alleviate
issues with extraction, enzymatic digestion and incomplete
derivatisation [42]. In addition, a deeper insight into the iden-
tity of the proteins can be obtained by tryptic digestion and
investigation of the Se-containing peptides formed [43].
Determination of Inter-batch and Inter-product Protein
Content Variation Between Se Yeast Products
In addition to the determination of the level of organic Se (as
SeMet), a series of analytical methods are routinely used to
ensure the quality and origin of the finished Se yeast product.
These include assessment of strain purity using biochemical
and genetic identification techniques, measurement of mois-
ture control and quantification of toxic impurities such as lead,
arsenic and cadmium [39]. In recent years, proteomic tech-
niques such as LC-MS are increasingly used to measure
changes in protein abundance across the samples that are be-
ing compared [44]. Relative quantifications allow the accurate
determination of protein ratios in samples that are genetically
or physiologically similar or diverse [45]. To determine the
variation in protein content between batches and products,
label-free mass-spectrometry-based proteomic analysis, scat-
ter correlation plots and hierarchical clustering were per-
formed. As previously mentioned, a proteomic approach such
as LC-MS/MS can circumvent potential issues with
extraction, enzymatic digestion and incomplete derivatisation
associated with Se speciation studies [40].
Scatter plots of protein intensities revealed high correlation
(low variation) between batches of the same products, indicat-
ing good reproducibility of batches and technical preparation
of samples (Fig. 2a–e). Pearson correlation coefficients (where
1 = identical) were calculated between all pairs of batches
within a product group, and these indicated that the lowest
variability was observed within the SELM-1 product group
(Pearson coefficient 0.983–0.985) which is to be expected as
there is only one production batch of this certified reference
material (CRM) available commercially. As the SELM-1 wa-
ter extract was prepared in triplicate from the same batch, the
low variation in this sample is reflective of the high reproduc-
ibility of the sample analysis, i.e. protein extraction, digestion
and LC-MS analysis. All batches clustered to their individual
product groups except for one. Yeast product 2 sample C
clustered closer to SELM-1 than the other products, which
may have resulted from an overall high similarity between
yeast product 2 and SELM-1 (Fig. 3: Pearson coefficient
0.948). Overall, these results indicate high sample reproduc-
ibility, which is of paramount importance for label-free quan-
titative (LFQ) proteomic analysis [46].
For determination of inter-product variation, a comparison
of all five products was also carried out using scatter plot
analysis and hierarchical clustering. The normalised intensi-
ties of all proteins were generated by MaxQuant analysis,
these values were log2(x) transformed and the mean value
was calculated for each product group. Yeast products 2–4
and SELM-1 all demonstrated a high level of correlation
(Fig. 3: Pearson coefficient >0.84 for all pairs) which makes
these products suitable for analysis within an LFQ proteomic
experiment [47]. However, LFQ proteomic analysis revealed
that yeast product 1 clustered independently of all other prod-
ucts based on protein composition (Fig. 3; Pearson coefficient
<0.56 for all pairs). Hierarchical clustering again confirmed
this poor correlation, with yeast product 1 grouping away
from the other Se-enriched products (Fig. 4a) thus highlight-
ing the need for multiple statistical analyses. The poor corre-
lation between yeast product 1 and all other products is in
agreement with the inconsistencies noted for SeMet
partitioning in this present study and previous studies address-
ing the composition of Se yeast products from different
sources [12]. This extent of variation makes yeast product
1 unsuitable for comparison in an LFQ proteomic ex-
periment, which is normally predicated on the basis that
the majority of proteins remain unchanged in a compar-
ison set [48]. With yeast product 1 excluded from the
analyses, a total of 786 proteins were identified across
the remaining four products, of which 374 proteins
displayed quantitative/qualitative changes in abundance
relative to SELM-1 (P value <0.05; fold change ≥2)
(Supplementary Table 1).
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Product 2 demonstrated the least disparity from SELM-1, and
these productswere also seen to cluster together on the heatmaps
(Fig. 4) again indicating high strain or product similarity. Al-
though proteomic analysis revealed overall batch reproducibility
of individual products, it also successfully differentiated outliers
and highlighted potential inconsistencies in production process-
es, which is in agreement with the previously discussed SeMet
standard deviation. In addition, although SeMet partitioning in-
dicated similar concentrations for products 2 and 3 in terms of
peptide-bound water-soluble SeMet, hierarchical clustering re-
vealed that product 3 is in fact the most dissimilar to product 2
and, indeed, all other products. A deeper insight into protein
abundances and identities (Fig. 4) can be achieved by further
interrogation of the data for Se-containing proteins.
Fig. 2 Multi-scatter correlation
plots of four selenium-enriched
products and SELM-1 reference
material. Scatter plots
demonstrating the variation
within product batches for yeast
products 1–4 (a–d), SELM-1 (e);
batches/replicates tested are
indicated (A–C). Axis values
represent the log2(x) value of the
normalised intensity of each
protein. Values in blue are
Pearson correlation coefficients
and indicate the level of variation
between sample groups (colour
figure online)
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Analysis for Se-Containing Proteins
Interrogation of the data generated from the four products
(excluding Yeast product 1) revealed the identification of a
number of selenopeptides (n = 186 unique peptides), corre-
sponding to 116 unique protein groups. These modifications
were associated with 172 SeMet replacements and 14
selenocysteines (SeCys). Proteins identified with SeMet/
SeCys containing peptides were extracted from the quantita-
tive results (Supplementary Table 1), and this subset is pre-
sented in Table 1 (62 proteins in total). A description of each
protein is provided along with its respective fold-change in
abundance (fold change ≥2) relative to SELM-1.
The Panel on Additives and Products or Substances used in
Animal Feed (FEEDAP Panel) has regularly expressed its
view that all SeMet sources would result in similar selenium
deposition (EFSA 2011a, b, 2012); this view was later extend-
ed to the hydroxy-analogue of SeMet (HMSeBA) (EFSA,
2013). Since L-SeMet is the predominant selenocompound
incorporated into proteins of Se yeast, the panel concluded
that there was no reason to assume that free L-SeMet would
result in an essentially different deposition pattern [49]. How-
ever, as SeMet is incorporated randomly into proteins as a
substitute for the sulphur analogue Met [25, 37, 50], the
degree of expression of particular proteins depends on the
yeast strain and the fermentation process [17] as clearly evi-
denced in Table 1.
The abundance changes reported are irrespective of Se
modification and represent the overall abundance of that pro-
tein in each of the products compared to SELM-1. The pro-
teins presented in Table 1 are a subset of the overall quantita-
tive results which have been selected based on the fact that
selenium modifications were also detected in these proteins.
For example, the relative levels of alcohol dehydrogenase
(Adh1) are measured based on all identified peptides (modi-
fied and unmodified). SeMet containing peptides were detect-
ed in Adh1 from products 2, 3 and SELM-1, but the overall
abundance of the Adh1 protein was significantly higher in
product 3 compared to SELM-1. Proteins with Se modifica-
tions including Ahp1, Bmh1, Eno1, Eno2, Sip18 and Mmf1
were also identified in previous studies on Se yeast [16, 25,
50, 51] thus corroborating the results presented in Table 1.
Three different isoforms of glyceraldehyde-3-phosphate dehy-
drogenase (Tdh1, Tdh2 and Tdh3) were also identified.
GAPDH is ubiquitous in yeast and has previously been report-
ed to incorporate SeMet randomly within the protein [17]. In
general, yeast supports a high degree of SeMet incorporation,
by replacing about 30 % of all Met with SeMet [24, 25, 50].
Fig. 3 Multi-scatter correlation
plots of four selenium-enriched
products and SELM-1 reference
material. Scatter plots
demonstrating the variation
within product batches for yeast
products 1–4 and SELM-1. Axis
values represent the log2(x) value
of the normalised intensity of
each protein. Variation between
the products, based on the mean
log-transformed intensity for each
protein, is shown. Values in blue
are Pearson correlation
coefficients and indicate the level
of variation between sample
groups. Yeast product 1 (red box)
demonstrated poor correlation to
all of the other products analysed
(Pearson coefficients <0.56)
(colour figure online)
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However, within peptides from the same protein, SeMet/Met
ratios will vary depending on the differential exposure to ox-
idative or enzymatic degradation of SeMet side chain and its
position in the protein (buried or exposed), and also to the
change in the production rate of each protein after Se addition
to growth media [50]. Differences in protein content might
also be ascribed to diverse manufacturing methods or
bioprocessing to which specific yeast is subjected during fer-
mentation, recovery and drying operations [52–54]. For ex-
ample, Tdh3 was identified in two products but at opposing
abundance levels. As glyceraldehyde-3-phosphate dehydro-
genase is involved in oxidation-reduction pathways, differen-
tial expression may be due to stress imposed by Se salt addi-
tion during fermentation, thus highlighting that a range of
divergent manufacturing methods may used to generate Se-
enriched yeast products [16, 39] resulting in inherent differ-
ences between preparations. It is clear that bioavailability of
SeMet will be dependent not only on the abundance of a
particular Se-containing protein but also on the position of
SeMet residues within the protein; therefore, consideration
must be given to the strain-specific deposition of Se into indi-
vidual protein and peptide-containing fractions [55]. As Se
yeast is produced commercially by methods which are
proprietary and/or patented [32, 56], there is a need for
straightforward protocols like the one presented, allowing rap-
id characterisation and quantitation of Se-enriched yeast sam-
ples [57].
Beside SeMet, Se is known to occur in SeCys and is re-
ferred to as the 21st amino acid because its specific insertion
into Se-proteins is directed by the SeCys insertion sequence
(SECIS) element [17]. As the S. cerevisiae genome does not
contain the SECIS element, SeCys in Se yeast can only be
inserted by the competition of Se with sulphur in the Cys
synthesis pathway, leading to the non-specific SeCys incorpo-
ration. SeCys was not formally identif ied in the
selenoproteome of Se yeast until recently, when Bierla et al.
demonstrated the considerable incorporation of SeCys in pro-
teins of the yeast proteome despite the absence of the UGA
codon [50]. Therefore, the identification of 14 SeCys modifi-
cations among four products in the present study significantly
adds to recent discoveries. In essence, this proteome level
characterisation of yeast products provides a unique finger-
print of product origin and reproducibility, which is essential
for regulatory and safety agencies to approve Se-enriched
yeast products for animal nutrition [17]. Further bioinformatic
interrogation of the data using Gene Ontology analysis iden-
tified a number of biological processes that showed variation
between each of the products compared to SELM-1.
Proteomic Comparison of Yeast Products to SELM-1 Using
Gene Ontology Analysis
Proteomic analysis revealed 374 individual proteins that
showed some change in abundance in either yeast product 2,
3 or 4 in comparison to the reference material SELM-1 (qual-
itative and quantitative results). In concordance with the pre-
viously reported hierarchical clustering heat maps, product 2
demonstrated the least variation from SELM-1, with 26 pro-
teins showing decreased abundance and 27 proteins increas-
ing in abundance compared to SELM-1, whereas product 3
demonstrated the most variation from SELM-1, with 112 pro-
teins showing decreased abundance and 171 increasing in
abundance. Bioinformatic interrogation of the data using
Gene Ontology analysis revealed a number of biological pro-
cesses that showed variation between each of the products
compared to SELM-1. A number of biological processes were
altered/affected in the individual products (when compared to
SELM-1), including translation, transcription, transport and
oxidation-reduction processes. The net number of proteins
that were higher or lower in abundance in each product,
categorised by biological process and relative to SELM-1, is
shown in Fig. 5.
It is well recognised that Se plays a key role in several
biological processes, including the response to oxidative
stress, DNA damage and repair [4, 58]. The results presented
in Fig. 5 demonstrate differential protein abundance between
Fig 4 Heat maps demonstrating the hierarchical clustering of a yeast
products 1–4 plus SELM-1 and b yeast products 2–4 plus SELM-1
(product 1 excluded), based on relative protein abundances. Low-
abundance proteins are depicted in green and high abundant proteins
are depicted in red. Grey shading indicates that protein was not
identified in the relevant product (colour figure online)
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Table 1 SeMet/SeCys-containing proteins with quantitative/qualitative changes in abundance relative to SELM-1
Fold Change 
Yeast Product 
2 v SELM-1
Fold Change 
Yeast Product 
3 v SELM-1
Fold Change 
Yeast Product 
4 v SELM-1 Gene Name Protein IDs Peptides
Sequence 
coverage 
[%]
Mol. weight 
[kDa] Protein Description
-2.6954 ADH1 YOL086C 20 61.8 36.849 Alcohol dehydrogenase
4.8329 ADH2 YMR303C 14 37.1 36.731 Glucose-repressible alcohol dehydrogenase II
-2.9690 -3.7902 -2.4416 AHP1 YLR109W 12 89.2 19.114 Thiol-specific peroxiredoxin
2.0078 ALD4 YOR374W 22 58.6 56.723 Mitochondrial aldehyde dehydrogenase
Unique to SELM-1 BMH1 YER177W 14 50.6 30.091 14-3-3 protein, major isoform
-3.7915 CMD1 YBR109C 13 97.3 16.135 Calmodulin
-2.1744 COX4 YGL187C 13 79.4 17.142 Subunit IV of cytochrome c oxidase
-5.3034 CYC1 YJR048W 12 67 12.182 Cytochrome c, isoform 1
-4.4841 DDR48 YMR173W 16 65.3 46.233 DNA damage-responsive protein
2.2927 EGD2 YHR193C 7 47.7 18.709 Alpha subunit of the heteromeric nascent 
polypeptide-associated complex (NAC) 
-2.1225 ENO1 YGR254W 31 81.2 46.816 Enolase I
-2.1858 ENO2 YHR174W 33 84.7 46.914 Enolase II
-5.4184 GAS5 YOL030W 9 25 51.869 1,3-beta-glucanosyltransferase
-2.0275 GIS2 YNL255C 8 60.1 17.103 Translational activator for mRNAs 
2.7239 GND1 YHR183W 15 39.9 53.543 6-phosphogluconate dehydrogenase 
-43.6679 -3.4679 HMF1 YER057C 9 96.9 13.906 Member of the p14.5 protein family with 
similarity to Mmf1p
-3.8409 HNT1 YDL125C 4 27.2 17.679 Adenosine 5'-monophosphoramidase
2.6416 HSP10 YOR020C 7 71.7 11.372 Mitochondrial matrix co-chaperonin that 
inhibits the ATPase activity of Hsp60p
Unique to 
Product 4
HSP82 YPL240C 26 37 81.405 Hsp90 chaperone required for pheromone 
signaling and negative regulation of Hsf1p
-3.0302 HYP2 YEL034W 10 75.2 17.114 Translation elongation factor eIF-5A 
3.9702 IGD1 YFR017C 10 64.6 21.783 Cytoplasmic protein that inhibits Gdb1p 
-3.5665 -6.7146 LEU2 YCL018W 25 77.5 38.952 Beta-isopropylmalate dehydrogenase (IMDH)
-3.2827 MET6 YER091C 42 59.5 85.859 Cobalamin-independent methionine synthase
-2.6696 MLC1 YGL106W 16 81.9 16.444 Essential light chain for Myo1p, light chain 
for Myo2p
-28.6555 -19.3447 MMF1 YIL051C 6 58.6 15.908 Mitochondrial protein 
2.6396 MSC1 YML128C 16 35.9 59.588 Protein of unknown function
2.3653 NHP6A YPR052C 8 63.4 10.802 High-mobility group (HMG) protein 
2.0664 NHP6B YBR089C-A 7 53.5 11.476 High-mobility group (HMG) protein 
-3.2049 -2.1213 OYE2 YHR179W 7 20 45.01 Conserved NADPH oxidoreductase 
containing flavin mononucleotide (FMN)
5.8820 -3.6778 PCK1 YKR097W 12 23 60.983 Phosphoenolpyruvate carboxykinase
-2.4620 2.6759 PET10 YKR046C 17 59.7 31.246 Protein of unknown function that co-purifies 
with lipid particles
-2.0013 -2.7838 PGM2 YMR105C 28 61.5 63.088 Phosphoglucomutase
-3.5104 -3.2205 PNC1 YGL037C 4 28.7 24.993 Nicotinamidase
4.4443 PRB1 YEL060C 13 21.1 69.621 Vacuolar proteinase B (yscB)
Fold changes are based on protein intensities as calculated usingMaxQuant LFQ algorithm and only proteinswith a significant change in abundance (P <
0.05; ≥2-fold change in abundance) are included. Positive numbers indicate increased abundance and negative figures indicated decreased abundance,
relative to the levels in SELM-1. Qualitative differences are also included and indicated as unique to a specific product. Values in red represent proteins
with a higher abundance in products 2, 3 or 4 relative to SELM-1, and green indicates a lower abundance of that protein relative to SELM-1 (quantitative
or qualitative) (colour table online)
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Se-enriched yeast products in a number of biological process-
es. Thus, the routes by which each of the individual product
compounds are metabolised and the relative abundance of
their metabolites will be entwined with the efficacy of Se
compounds in disease prevention and treatment [31]. It is also
worth noting that the water extraction used in this study is
vastly different from volatile conditions encountered in the
GI tract where conditions will solubilise some proteins and
Table 1 (continued)
Fold Change 
Yeast Product 
2 v SELM-1
Fold Change 
Yeast Product 
3 v SELM-1
Fold Change 
Yeast Product 
4 v SELM-1 Gene Name Protein IDs Peptides
Sequence 
coverage 
[%]
Mol. weight 
[kDa] Protein Description
2.0046 QCR6 YFR033C 4 32 17.257 Subunit 6 of the ubiquinol cytochrome-c 
reductase complex
2.3357 RDL1 YOR285W 10 89.9 15.413 Protein of unknown function containing a 
rhodanese-like domain
2.1302 -2.5972 RNQ1 YCL028W 6 21.7 42.579 [PIN(+)] prion
3.1941 RPL31A YDL075W 6 55.8 12.953 Protein component of the large (60S) 
ribosomal subunit
-2.1036 RPN10 YHR200W 3 12.3 29.747 Non-ATPase base subunit of the 19S 
regulatory particle (RP) of the 26S 
proteasome
2.2727 RPS21B YJL136C 8 70.1 9.7597 Protein component of the small (40S) 
ribosomal subunit
2.0833 RPS28B YLR264W 2 31.3 7.5647 Protein component of the small (40S) 
ribosomal subunit
-3.2101 RTN1 YDR233C 15 52.2 32.916 ER membrane protein
-3.0527 -4.6430 SIP18 YMR175W 4 40.5 8.8738 Phospholipid-binding hydrophilin
2.0810 -2.2447 SMT3 YDR510W 4 46.5 11.597 Ubiquitin-like protein of the SUMO family
-33.7974 SOD2 YHR008C 8 58.8 25.774 Mitochondrial manganese superoxide 
dismutase
3.8648 SPG4 YMR107W 13 85.2 13.18 Protein required for survival at high 
temperature during stationary phase
-2.9821 TDH1 YJL052W 24 70.8 35.75 Glyceraldehyde-3-phosphate dehydrogenase, 
isozyme 1
-3.7794 TDH2 YJR009C 18 63 35.846 Glyceraldehyde-3-phosphate dehydrogenase, 
isozyme 2
-2.6172 2.5432 TDH3 YGR192C 26 84.3 35.746 Glyceraldehyde-3-phosphate dehydrogenase, 
isozyme 3
2.1526 TEF2 YBR118W 15 40 50.032 Translational elongation factor EF-1 alpha
5.7402 TFS1 YLR178C 10 65.3 24.357 Protein that interacts with and inhibits 
carboxypeptidase Y and Ira2p
4.0509 TMA17 YDL110C 8 61.3 16.771 Protein of unknown function that associates 
with ribosomes
-2.3043 TPM2 YIL138C 19 75.8 19.093 Minor isoform of tropomyosin,
-5.6927 TRX1 YLR043C 7 66 11.235 Cytoplasmic thioredoxin isoenzyme 
2.3791 3.9860 UIP4 YPL186C 7 25.3 34.221 Protein that interacts with Ulp1p
-5.7427 VHS2 YIL135C 8 23.4 47.96 Cytoplasmic protein of unknown function
Unique to SELM-1 YDL218W YDL218W 3 18.6 34.449 Putative protein of unknown function
-2.4504 YGR169C-A YGR169C-A 3 37 10.495 Putative protein of unknown function
-2.6021 YIL002W-A YIL002W-A 3 53.6 7.7286 Putative protein of unknown function
-3.0034 YMR074C YMR074C 10 63.4 15.977 Protein with homology to human PDCD5
6.8073 2.5860 YNL195C YNL195C 15 85.8 28.321 Putative protein of unknown function
-3.2666 YOR020W-A YOR020W-A 3 35.6 9.6176 Putative protein of unknown function
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destabilise others [59]. Therefore, the extent to which the ac-
tive forms of yeast proteins identified can be transported intact
across the intestinal barrier, and the biological effect of such
proteins or corresponding peptides must be determined in pre-
clinical animal models before any definitive conclusions can
be made on potential beneficial health effects [16]. Neverthe-
less, knowledge of a group of proteins that respond to Se
supplementation will be useful in the assessment of a particu-
lar metabolic status [60].
KEGG Metabolic Pathway Analysis
Using KEGG pathway analysis [61] and FungiFun analysis
[62], the enzymes with altered abundances relative to SELM-
1 were mapped on the glutathione metabolism and Cys/Met
metabolism pathways (Fig. 6). These pathwayswere previously
observed to be altered in response to Se, and Se-containing
proteins that underwent a significant change in abundance have
been identified (data not shown). Proteins involved in Cys/Met
metabolism were mapped to show the effect of product differ-
ence on proteins from this pathway (Fig. 6a). For example, the
protein encoded by SPE3 (spermidine synthase), which utilises
S-adenosylmethioninamine for the production of spermidine,
demonstrated increased abundance in product 4 only, once
again demonstrating differences between the products. This
may signify an increase in the production of spermidine, which
is associated with increased cell lifespan and suppression of
oxidative stress in yeast [63].
One protein, Sam2, which is involved inMet conversion to
S-adenosyl methionine (SAM) was observed at a significantly
higher level in products 3 and 4 compared to SELM-1
(Fig. 6a). SAM, also known as AdoMet, is an essential
molecule that exists in all living organisms and is also a pre-
cursor molecule in the aminopropylation and transulfuration
pathways [64]. It is distributed to virtually all body tissues and
fluids and is of fundamental importance in a number of bio-
chemical reactions involving enzymatic transmethylation,
contributing to the synthesis, activation and/or metabolism
of such compounds as hormones, neurotransmitters, nucleic
acids, proteins and phospholipids [20, 65, 66]. SAM is effec-
tive in the treatment of clinical disorders such as liver disease,
osteoarthritis and depression and has been used extensively as
an approved prescription medicinal dietary supplement in Eu-
rope. Chu et al. [67] recently reported the urgent need to en-
hance the production of SAM to meet growing demand. No-
tably, S. cerevisiae has two distinct SAM-synthetase genes,
named SAM1 and SAM2, which arose from gene duplication
[68] and share a high degree of similarity [69]. Although
SAM1 and SAM2 encode functionally equivalent SAM syn-
thetases, they are regulated differently [70]. Both genes un-
dergo feedback repression by SAM, like other genes of sul-
phur aminoacid metabolism, but expression of SAM2 also
increases during growth, which overrides the SAM-mediated
repression [64, 70]. Thomas et al. [69] also reported that
SAM1 and SAM2 are regulated transcriptionally by excess
methionine in the growthmedium, but in an opposingmanner.
Expression of the SAM2 gene is induced by the presence of
methionine in the growthmedium, whereas SAM1 is repressed
[69].
Interestingly, S-adenosylhomocysteine hydrolase (Sah1)
and methionine synthase (Met6) are also involved in the
SAM cycle, also known as the activated methyl cycle. Within
this cycle, upon donating the methyl group, SAM is converted
to S-adenosylhomocysteine (AdoHcy) which is then
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hydrolyzed to homocysteine by Sah1 [71]. Inhibition of Sah1
normally results in an accumulation of cellular AdoHcy,
which is often accompanied by a simultaneous rise in SAM
because of the feedback inhibition by AdoHcy on most meth-
ylation reactions [72]. Therefore, as can be appreciated in
Fig. 6a, the production of SAM is clearly influenced by choice
of production strain and/or manipulation of culture conditions.
Similarly, a number of proteins associated with glutathione
metabolism were detected (Fig. 6b). Proteins encoded by
OXP1, DUG1, GND1, GTT1, SPE3, RNR2 and RNR4 were
annotated to the glutathione metabolism KEGG pathway,
which was significantly represented in the data (P =
0.00008; FungiFun analysis, data not shown). The chemical
and physical resemblance between Se and S establishes that
both these elements share common metabolic pathways [73].
In addition to being a constituent of cysteine and methionine,
sulphur (S) is also present in glutathione, an essential metab-
olite in almost all eukaryotic organisms playing a key role in
redox homeostasis and in the cellular response to oxidative
stress [74]. Expression of glutathione S-transferase (Gtt1) is
reportedly induced after diauxic shift and remains high
throughout the stationary phase [75], while phosphogluconate
dehydrogenase (Gnd1) is important for protecting yeast from
oxidative stress [76]. Glutathione utilisation in S. cerevisiae
has also been shown to be dependent on the presence of a
glutathione transporter and an alternative pathway of
glutathione degradation that involves the ‘Dug pathway com-
plex’ comprising Dug1 [74]. The remaining annotated pro-
teins have peripheral roles in glutathione metabolism. For ex-
ample, Oxp1 is a 5-oxoprolinase which functions to produce
glutamate and normally forms part of the gamma-glutamyl
cycle [77].
As S. cerevisiae is unable to distinguish between Se and S
[73], it is unsurprising that Se supplementation affected the
levels of these glutathione metabolism-related proteins in Se
yeast products. Both Gtt1 and Gnd1 were observed to increase
in abundance following Se enrichment and were present at
significantly higher levels in product 4 compared to SELM-
1. An additional glutathione transferase, Ecm4, was also
uniquely identified in product 4. Other glutathione
metabolism-related proteins were detected at significantly
lower levels in either product 3 or product 2 relative to
SELM-1. It is worth noting that SAM is also the principal
biological methyl donor and a precursor for glutathione [78].
Once again, product 2 is identified to be the most dissimilar to
all other products analysed; however, all products demonstrat-
ed differential protein abundance relative to SELM-1. Alto-
gether, these results point to the pathways and systems that are
affected following Se enrichment yet differ considerably
among the Se-enriched yeast products examined.
Conclusion
To date, speciation data have made it possible to discrim-
inate between yeast containing organic Se and yeast mixed
with inorganic selenate or selenite, to distinguish Se-rich
yeasts produced by different manufacturers and to verify
batch-to-batch reproducibility. Recent advances in mass
spectrometry and quantitative proteomics enable analysis
of proteins in a much more comprehensive and high-
throughput manner than previously possible. In addition,
the availability of SELM-1 reference material has im-
proved the quality assurance of the analyses of Se-
enriched yeast. In this study, we have demonstrated that
commercial Se-enriched yeast products differ significantly
in terms of protein abundance and associated metabolic
pathways in addition to SeMet content. In essence, all of
the presented data confirm that Se yeast products are dis-
tinct from each other. This distinctness is due to the dif-
ferential deposition of Se present within individual yeast
fractions indicating that retention and thus bioavailability
of Se from each of these products are different. Investi-
gating the bioavailability of Se yeast products using
in vitro digestion will further differentiate the products in
terms of bio efficacy.
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